Return to search

Nabla Bio rakes in $11m seed

Nabla Bio, a next-generation antibody design company, has secured $11 million in seed financing.

Nabla Bio, a next-generation antibody design company, has secured $11 million in seed financing. Khosla Ventures and Zetta Venture Partners led the round.

Source: Press Release